SEMA4C as a Relapse Biomarker in Breast Cancer

NCT03663153 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

4200

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

OTHER: SEMA4C high value follow-up group
OTHER: SEMA4C low value follow-up group

Sponsor

Tongji Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]